Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study.

Daan M VoetenLeonie R van der WerfJanneke A WilschutLinde A D BusweilerJohanna W van SandickRichard van HillegersbergMark I van Berge Henegouwennull null

Published in: Annals of surgical oncology (2021)

Failure to cure has an incidence of 22% in patients undergoing gastric cancer surgery. Higher failure to cure rates were seen in centers administering less neoadjuvant chemotherapy, which confirms the Dutch guideline recommendation on the administration of neoadjuvant chemotherapy. Failure to cure provides short loop feedback and can be used as a quality indicator in surgical audits.

Keyphrases

neoadjuvant chemotherapy
patients undergoing
locally advanced
lymph node
sentinel lymph node
minimally invasive
coronary artery bypass
rectal cancer
risk factors
squamous cell carcinoma
transcription factor
surgical site infection
acute coronary syndrome